Cita APA

Bendell, J. C., Sauri, T., Gracián, A. C., Alvarez, R., López‐López, C., García‐Alfonso, P., . . . Hurwitz, H. (2019). The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC). Oncologist.

Citación estilo Chicago

Bendell, Johanna C., et al. "The McCAVE Trial: Vanucizumab Plus MFOLFOX‐6 Versus Bevacizumab Plus MFOLFOX‐6 in Patients With Previously Untreated Metastatic Colorectal Carcinoma (mCRC)." Oncologist 2019.

Cita MLA

Bendell, Johanna C., et al. "The McCAVE Trial: Vanucizumab Plus MFOLFOX‐6 Versus Bevacizumab Plus MFOLFOX‐6 in Patients With Previously Untreated Metastatic Colorectal Carcinoma (mCRC)." Oncologist 2019.